Anti-PPP3CA monoclonal antibody

Pre-made anti-PPP3CA monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PPP3CA/PPP3CA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T25464-Ab-1/ GM-Tg-hg-T25464-Ab-2Anti-Human PPP3CA monoclonal antibodyHuman
GM-Tg-rg-T25464-Ab-1/ GM-Tg-rg-T25464-Ab-2Anti-Rat PPP3CA monoclonal antibodyRat
GM-Tg-mg-T25464-Ab-1/ GM-Tg-mg-T25464-Ab-2Anti-Mouse PPP3CA monoclonal antibodyMouse
GM-Tg-cynog-T25464-Ab-1/ GM-Tg-cynog-T25464-Ab-2Anti-Cynomolgus/ Rhesus macaque PPP3CA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T25464-Ab-1/ GM-Tg-felg-T25464-Ab-2Anti-Feline PPP3CA monoclonal antibodyFeline
GM-Tg-cang-T25464-Ab-1/ GM-Tg-cang-T25464-Ab-2Anti-Canine PPP3CA monoclonal antibodyCanine
GM-Tg-bovg-T25464-Ab-1/ GM-Tg-bovg-T25464-Ab-2Anti-Bovine PPP3CA monoclonal antibodyBovine
GM-Tg-equg-T25464-Ab-1/ GM-Tg-equg-T25464-Ab-2Anti-Equine PPP3CA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T25464-Ab-1/ GM-Tg-hg-T25464-Ab-2; GM-Tg-rg-T25464-Ab-1/ GM-Tg-rg-T25464-Ab-2;
GM-Tg-mg-T25464-Ab-1/ GM-Tg-mg-T25464-Ab-2; GM-Tg-cynog-T25464-Ab-1/ GM-Tg-cynog-T25464-Ab-2;
GM-Tg-felg-T25464-Ab-1/ GM-Tg-felg-T25464-Ab-2; GM-Tg-cang-T25464-Ab-1/ GM-Tg-cang-T25464-Ab-2;
GM-Tg-bovg-T25464-Ab-1/ GM-Tg-bovg-T25464-Ab-2; GM-Tg-equg-T25464-Ab-1/ GM-Tg-equg-T25464-Ab-2
Products NameAnti-PPP3CA monoclonal antibody
Formatmab
Target NamePPP3CA
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PPP3CA monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T25464-Ag-1Recombinant multi-species PP2BA/ PPP3CA/ CALN protein


    Target information

    Target IDGM-T25464
    Target NamePPP3CA
    Gene ID5530,19055,24674,709773,403486,101097144,286852,100067434
    Gene Symbol and Synonyms2900074D19Rik,ACCIID,CALN,CALNA,CALNA1,CCN1,CN,CnA,CNA1,DEE91,IECEE,IECEE1,PPP2B,PPP3CA
    Uniprot AccessionQ08209,P63329,P48452
    Uniprot Entry NamePP2BA_HUMAN,PP2BA_RAT,PP2BA_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000138814
    Target ClassificationN/A

    The target: PPP3CA, gene name: PPP3CA, also named as CALN, CALNA, CALNA1, CCN1, CNA1, IECEE, IECEE1, PPP2B. Enables several functions, including ATPase binding activity; calmodulin binding activity; and calmodulin-dependent protein phosphatase activity. Involved in several processes, including calcineurin-NFAT signaling cascade; peptidyl-serine dephosphorylation; and response to calcium ion. Located in several cellular components, including cytosol; dendritic spine; and nucleoplasm. Part of calcineurin complex. Colocalizes with cytoplasmic side of plasma membrane. Implicated in developmental and epileptic encephalopathy 91. Biomarker of focal segmental glomerulosclerosis and schizophrenia. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.